LOSS OF P53 PROTEIN DURING RADIATION TRANSFORMATION OF PRIMARY HUMAN MAMMARY EPITHELIAL-CELLS

被引:72
作者
WAZER, DE
CHU, QM
LIU, XL
GAO, QS
SAFAII, H
BAND, V
机构
[1] TUFTS UNIV NEW ENGLAND MED CTR,DEPT RADIAT ONCOL,BOX 824,750 WASHINGTON ST,BOSTON,MA 02111
[2] TUFTS UNIV NEW ENGLAND MED CTR,DEPT PATHOL,BOSTON,MA 02111
[3] TUFTS UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02111
关键词
D O I
10.1128/MCB.14.4.2468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The causative factors leading to breast cancer are largely unknown. Increased incidence of breast cancer following diagnostic or therapeutic radiation suggests that radiation may contribute to mammary oncogenesis. This report describes the in vitro neoplastic transformation of a normal human mammary epithelial cell strain, 76N, by fractionated gamma-irradiation at a clinically used dose (30 Gy). The transformed cells (76R-30) were immortal, had reduced growth factor requirements, and produced tumors in nude mice. Remarkably, the 76R-30 cells completely lacked the p53 tumor suppressor protein. Loss of p53 was due to deletion of the gene on one allele and a 26-bp deletion within the third intron on the second allele which resulted in abnormal splicing out of either the third or fourth exon from the mRNA. PCR with a mutation-specific primer showed that intron 3 mutation was present in irradiated cells before selection for immortal phenotype. 76R-30 cells did not exhibit G, arrest in response to radiation, indicating a loss of p53-mediated function. Expression of the wild-type p53 gene in 76R-30 cells led to their growth inhibition. Thus, loss of p53 protein appears to have contributed to neoplastic transformation of these cells. This unique model should facilitate analyses of molecular mechanisms of radiation-induced breast cancer and allow identification of p53-regulated cellular genes in breast cells.
引用
收藏
页码:2468 / 2478
页数:11
相关论文
共 44 条
[31]   WILD-TYPE P53 IS A CELL-CYCLE CHECKPOINT DETERMINANT FOLLOWING IRRADIATION [J].
KUERBITZ, SJ ;
PLUNKETT, BS ;
WALSH, WV ;
KASTAN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7491-7495
[32]   CHARACTERIZATION OF THE HUMAN P53-GENE [J].
LAMB, P ;
CRAWFORD, L .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (05) :1379-1385
[33]  
MACKAY J, 1988, LANCET, V2, P1384
[34]   GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS [J].
MALKIN, D ;
LI, FP ;
STRONG, LC ;
FRAUMENI, JF ;
NELSON, CE ;
KIM, DH ;
KASSEL, J ;
GRYKA, MA ;
BISCHOFF, FZ ;
TAINSKY, MA ;
FRIEND, SH .
SCIENCE, 1990, 250 (4985) :1233-1238
[35]   MALIGNANT TRANSFORMATION OF HUMAN FIBROBLASTS PREVIOUSLY IMMORTALIZED WITH CO-60 GAMMA-RAYS [J].
MIHARA, K ;
BAI, L ;
KANO, Y ;
MIYAZAKI, M ;
NAMBA, M .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (04) :639-643
[36]   NEOPLASTIC TRANSFORMATION OF HUMAN-DIPLOID FIBROBLASTS (KMST-6) BY TREATMENT WITH CO-60 GAMMA-RAYS [J].
NAMBA, M ;
NISHITANI, K ;
HYODOH, F ;
FUKUSHIMA, F ;
KIMOTO, T .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (02) :275-280
[37]   MUTATIONS IN P53 AS POTENTIAL MOLECULAR MARKERS FOR HUMAN BREAST-CANCER [J].
RUNNEBAUM, IB ;
NAGARAJAN, M ;
BOWMAN, M ;
SOTO, D ;
SUKUMAR, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10657-10661
[38]   TUMOR SUPPRESSOR GENES - THE PUZZLE AND THE PROMISE [J].
SAGER, R .
SCIENCE, 1989, 246 (4936) :1406-1412
[39]  
SAGER R, 1984, CANCER CELL, V2, P487
[40]   GERM-LINE TRANSMISSION OF A MUTATED P53 GENE IN A CANCER-PRONE FAMILY WITH LI-FRAUMENI SYNDROME [J].
SRIVASTAVA, S ;
ZOU, ZQ ;
PIROLLO, K ;
BLATTNER, W ;
CHANG, EH .
NATURE, 1990, 348 (6303) :747-749